◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Nxera Pharma Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
+Operating Income -2.8B -- -3.7B -- -- --
Operating Margin % 74.0% -- 115.7% -- -- --
+Ordinary Income -3.7B -- -3.2B -- -- --
Revenue Growth % -- -- -- -- -- --
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 09, 2024Q4 2023Dec 31, 2023Q4 2022Dec 31, 2022Q4 2021Dec 31, 2021
Current Assets 53.8B -- 63.6B -- -- --
Total Assets 144.7B 152.3B 156.5B 104.1B 91.2B 81.3B
Total Liabilities 78.8B 86.4B 87.5B 41.4B 34.9B 25.6B
Total Equity 65.9B 65.9B 69.0B 62.7B 56.4B 55.8B
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...